Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics

Heron Therapeutics, Inc. (HRTX): $1.03

0.06 (+6.19%)

POWR Rating

Component Grades








Add HRTX to Watchlist
Sign Up

Industry: Biotech




#152 of 356

in industry

HRTX Price/Volume Stats

Current price $1.03 52-week high $4.68
Prev. close $0.97 52-week low $0.93
Day low $0.96 Volume 931,000
Day high $1.05 Avg. volume 2,069,337
50-day MA $1.46 Dividend yield N/A
200-day MA $1.94 Market Cap 144.98M

HRTX Stock Price Chart Interactive Chart >


  • Value is the dimension where HRTX ranks best; there it ranks ahead of 73.5% of US stocks.
  • HRTX's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • HRTX's current lowest rank is in the Stability metric (where it is better than 9.26% of US stocks).

HRTX Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for HRTX is -3 -- better than only 3.76% of US stocks.
  • HRTX's went public 36.11 years ago, making it older than 91.99% of listed US stocks we're tracking.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -64.33 for HERON THERAPEUTICS INC; that's greater than it is for only 0.36% of US stocks.
  • If you're looking for stocks that are quantitatively similar to HERON THERAPEUTICS INC, a group of peers worth examining would be RAMP, RPD, ASAN, BLZE, and BFLY.
  • Visit HRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.herontx.com.

HRTX Valuation Summary

  • In comparison to the median Healthcare stock, HRTX's price/sales ratio is 70% lower, now standing at 1.2.
  • HRTX's price/sales ratio has moved down 6.7 over the prior 243 months.

Below are key valuation metrics over time for HRTX.

Stock Date P/S P/B P/E EV/EBIT
HRTX 2023-09-22 1.2 -3.6 -1.0 -2.1
HRTX 2023-09-21 1.3 -3.9 -1.1 -2.2
HRTX 2023-09-20 1.3 -4.0 -1.2 -2.2
HRTX 2023-09-19 1.4 -4.1 -1.2 -2.2
HRTX 2023-09-18 1.4 -4.1 -1.2 -2.2
HRTX 2023-09-15 1.4 -4.3 -1.2 -2.3

HRTX Growth Metrics

    The 4 year revenue growth rate now stands at 2745.98%.
  • The 2 year net cashflow from operations growth rate now stands at -89.28%.
  • The 5 year net cashflow from operations growth rate now stands at 28.78%.
HRTX's revenue has moved up $15,268,000 over the prior 15 months.

The table below shows HRTX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 98.299 -154.636 -216.801
2022-06-30 94.972 -170.736 -227.301
2022-03-31 89.785 -205.355 -231.957
2021-12-31 86.346 -203.354 -220.683
2021-09-30 86.296 -210.65 -228.318
2021-06-30 83.031 -199.538 -234.138

HRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HRTX has a Quality Grade of D, ranking ahead of 9.05% of graded US stocks.
  • HRTX's asset turnover comes in at 0.243 -- ranking 181st of 682 Pharmaceutical Products stocks.
  • IBIO, COLL, and PTGX are the stocks whose asset turnover ratios are most correlated with HRTX.

The table below shows HRTX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.243 0.485 -0.993
2021-06-30 0.228 0.515 -1.093
2021-03-31 0.224 0.582 -1.080
2020-12-31 0.214 0.592 -0.933
2020-09-30 0.227 0.586 -0.779
2020-06-30 0.277 0.581 -0.676

HRTX Price Target

For more insight on analysts targets of HRTX, see our HRTX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $33.00 Average Broker Recommendation 1.42 (Moderate Buy)

Heron Therapeutics, Inc. (HRTX) Company Bio

Heron Therapeutics is a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs. The company was founded in 1983 and is based in Redwood City, CA.

HRTX Latest News Stream

Event/Time News Detail
Loading, please wait...

HRTX Latest Social Stream

Loading social stream, please wait...

View Full HRTX Social Stream

Latest HRTX News From Around the Web

Below are the latest news stories about HERON THERAPEUTICS INC that investors may wish to consider to help them evaluate HRTX as an investment opportunity.

11 Best Long-Term Penny Stocks to Buy Now

In this article, we will take a look at the 11 best long-term penny stocks to buy now. To see more such companies, go directly to 5 Best Long-Term Penny Stocks to Buy Now. The Federal Reserve’s historic battle against inflation that started in 2022 has highlighted the importance of an already-known fact: if you […]

Yahoo | August 24, 2023

Heron Therapeutics (HRTX) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Yahoo | August 15, 2023

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript August 14, 2023 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $0.23. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call. As a reminder, this conference […]

Yahoo | August 15, 2023

Q2 2023 Heron Therapeutics Inc Earnings Call

Q2 2023 Heron Therapeutics Inc Earnings Call

Yahoo | August 15, 2023

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures

Key Insights Institutions' substantial holdings in Heron Therapeutics implies that they have significant influence over...

Yahoo | August 15, 2023

Read More 'HRTX' Stories Here

HRTX Price Returns

1-mo -34.39%
3-mo N/A
6-mo -45.79%
1-year -75.59%
3-year -92.95%
5-year -96.78%
YTD -58.80%
2022 -72.62%
2021 -56.86%
2020 -9.94%
2019 -9.41%
2018 43.31%

Continue Researching HRTX

Here are a few links from around the web to help you further your research on Heron Therapeutics Inc's stock as an investment opportunity:

Heron Therapeutics Inc (HRTX) Stock Price | Nasdaq
Heron Therapeutics Inc (HRTX) Stock Quote, History and News - Yahoo Finance
Heron Therapeutics Inc (HRTX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!